| Terminated | Study of Ciraparantag for Reversal of Anticoagulation Induced by Edoxaban, Apixaban or Rivaroxaban in Healthy Healthy | Phase 2 | 2021-10-13 |
| Recruiting | A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects Iron Deficiency Anemia | Phase 3 | 2019-09-18 |
| Completed | Study to Evaluate Rate of Nausea in Healthy Premenopausal Female Subjects Treated With Single Dose of Bremelan Nausea | Phase 1 | 2019-06-17 |
| Recruiting | A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for th Chronic Kidney Disease; Iron Deficiency Anemia | Phase 3 | 2018-08-13 |
| Terminated | Study of the Efficacy and Safety of AMAG-423 (Digoxin Immune Fab) in Antepartum Subjects With Severe Preeclamp Severe Preeclampsia | Phase 2 / Phase 3 | 2017-04-12 |
| Terminated | Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administere Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal Women | Phase 3 | 2016-10-07 |
| Completed | Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) i Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women | Phase 1 | 2016-09-01 |
| Completed | A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Iron Deficiency Anemia | Phase 3 | 2016-02-29 |
| Completed | Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemod Iron Deficiency Anemia Treatment, Chronic Kidney Disease(CKD) | Phase 4 | 2013-08-01 |
| Terminated | A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chr Iron Deficiency Anemia | Phase 3 | 2011-12-27 |
| Terminated | A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis- Iron Deficiency Anemia, Nondialysis-dependent Chronic Kidney Disease | Phase 3 | 2011-10-17 |
| Terminated | A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidn Iron Deficiency Anemia | Phase 3 | 2011-10-17 |
| Completed | A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Receive Children Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy Trial | — | 2010-11-09 |
| Completed | A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia Iron Deficiency Anemia | Phase 3 | 2010-08-10 |
| Completed | A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia Iron Deficiency Anemia | Phase 3 | 2010-07-27 |
| Completed | A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia Iron Deficiency Anemia | Phase 3 | 2010-06-19 |
| Completed | A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects Wi Iron Deficiency, Anemia, Kidney Disease | Phase 2 | 2010-03-01 |
| Completed | Confirmatory Study of 17P vs Vehicle for Prevention of Preterm Birth in Women w/ Previous Spontaneous Preterm Preterm Birth | Phase 3 | 2009-10-01 |
| Completed | Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD) Peripheral Arterial Disease (PAD) | Phase 2 | 2008-09-01 |
| Completed | A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women Anemia | Phase 1 | 2006-05-01 |
| Completed | A Crossover Safety Study of Ferumoxytol Versus Placebo Anemia | Phase 3 | 2005-01-01 |
| Completed | Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Hemodialysis Patients Anemia | Phase 3 | 2004-08-01 |
| Completed | Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patie Anemia | Phase 3 | 2004-06-01 |
| Completed | Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patie Anemia | Phase 3 | 2004-05-01 |